{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:08:04Z","timestamp":1784117284179,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejso.2025.109649","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:54:28Z","timestamp":1738209268000},"page":"109649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after gynecological cancer surgery: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8144-7844","authenticated-orcid":false,"given":"Guilherme","family":"Reis Romualdo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4718-8840","authenticated-orcid":false,"given":"Matheus Eduardo","family":"Soares Pinhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00edssa \u00camily","family":"Andrade Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7060-1053","authenticated-orcid":false,"given":"Gabriel","family":"Lage Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-6654","authenticated-orcid":false,"given":"Eduardo","family":"Batista C\u00e2ndido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-7861","authenticated-orcid":false,"given":"Agnaldo","family":"Lopes da Silva Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejso.2025.109649_bib1","doi-asserted-by":"crossref","first-page":"140.e1","DOI":"10.1016\/j.ajog.2023.04.045","article-title":"Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery","volume":"229","author":"Taylor","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109649_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.AOG.0000200046.28199.ae","article-title":"Pulmonary embolism after major abdominal surgery in gynecologic oncology","volume":"107","author":"Martino","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109649_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2018.11.021","article-title":"Beyond prophylaxis: extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer","volume":"152","author":"Wagner","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109649_bib4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ygyno.2007.03.004","article-title":"Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review","volume":"105","author":"Einstein","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.109649_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.ejso.2025.109649_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2021.01.012","article-title":"Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathway","volume":"200","author":"Ward","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejso.2025.109649_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.thromres.2020.09.019","article-title":"The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: a meta-analysis","volume":"196","author":"Ma","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejso.2025.109649_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2023.04.009","article-title":"Enhanced recovery after surgery (ERAS\u00ae) society guidelines for gynecologic oncology: addressing implementation challenges - 2023 update","volume":"173","author":"Nelson","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109649_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2012.11.027","article-title":"Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies","volume":"128","author":"Schmeler","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109649_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2021.01.027","article-title":"Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: a systematic review and network meta-analysis","volume":"161","author":"Insin","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.109649_bib11","doi-asserted-by":"crossref","unstructured":"Marchocki Z, Norris L, O'Toole S, Gleeson N, Saadeh FA. Patients' experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational study. Int J Gynecol Cancer. Published online April 16, 2019:ijgc-2019-000284. doi:10.1136\/ijgc-2019-000284.","DOI":"10.1136\/ijgc-2019-000284"},{"issue":"1","key":"10.1016\/j.ejso.2025.109649_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2020.11.020","article-title":"Direct oral anticoagulant use in gynecologic oncology: a society of gynecologic oncology clinical practice statement","volume":"160","author":"Gressel","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.109649_bib13","doi-asserted-by":"crossref","unstructured":"Zhou H, Ye LL, Zhou JT, Ma FX, Ma JJ, Zhang JH. Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal\/pelvic cancer-related surgery: a systematic review and meta-analysis. Surg Endosc. Published online January 24, 2024. doi:10.1007\/s00464-023-10649-y.","DOI":"10.1007\/s00464-023-10649-y"},{"issue":"1","key":"10.1016\/j.ejso.2025.109649_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12957-024-03341-5","article-title":"Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis","volume":"22","author":"Zhou","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109649_bib15","series-title":"Cochrane Handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/j.ejso.2025.109649_bib16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejso.2025.109649_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemostasis"},{"issue":"11","key":"10.1016\/j.ejso.2025.109649_bib18","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.ejso.2025.109649_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2025.109649_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221132556","article-title":"Rivaroxaban versus Enoxaparin for Thromboprophylaxis after major Gynecological Cancer Surgery: the VALERIA Trial: V enous thromboembolism prophyl A xis after gyneco L ogical p E lvic cancer surgery with RI varoxaban versus enox A parin (VALERIA trial)","volume":"28","author":"Longo De Oliveira","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejso.2025.109649_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2023.02.012","article-title":"Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy","volume":"172","author":"Sp\u00e9nard","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.109649_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2024.06.013","article-title":"Avoiding the needle: a quality improvement program introducing apixaban for extended thromboprophylaxis after major gynecologic cancer surgery","volume":"188","author":"Stewart","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.109649_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2024.01.039","article-title":"Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center","volume":"183","author":"Knisely","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.109649_bib24","first-page":"1","article-title":"The effect of oral and injectable anticoagulant drugs on bleeding rate in patients undergoing gynecological oncological surgeries","volume":"26","author":"Aminimoghaddam","year":"2024","journal-title":"Iran J Obstet Gynecol Infertil"},{"issue":"8","key":"10.1016\/j.ejso.2025.109649_bib25","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1245\/s10434-024-15369-8","article-title":"Validation of the safety and efficacy of apixaban as postoperative thromboembolism prophylaxis for patients with gynecologic malignancies","volume":"31","author":"Floyd","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109649_bib26","doi-asserted-by":"crossref","unstructured":"Douketis JD, Spyropoulos AC. Perioperative management of patients taking direct oral anticoagulants: a review. JAMA. Published online August 12, 2024. doi:10.1001\/jama.2024.12708.","DOI":"10.1001\/jama.2024.12708"},{"key":"10.1016\/j.ejso.2025.109649_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis","volume":"173","author":"Li","year":"2019","journal-title":"Thromb Res"},{"issue":"7","key":"10.1016\/j.ejso.2025.109649_bib28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1055\/s-0040-1712098","article-title":"Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis","volume":"120","author":"Giustozzi","year":"2020","journal-title":"Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.ejso.2025.109649_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2020.07.096","article-title":"Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery","volume":"159","author":"Glickman","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.109649_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619849103","article-title":"Cost-effectiveness evaluations among the direct oral anticoagulants for the prevention and treatment of venous thromboembolism: systematic review","volume":"25","author":"Al Mukdad","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"10.1016\/j.ejso.2025.109649_bib31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/AOG.0b013e3181f240f7","article-title":"Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery","volume":"116","author":"Nick","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109649_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ygyno.2013.04.024","article-title":"Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study","volume":"130","author":"Kumar","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109649_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2016.06.002","article-title":"Venous thromboembolism following minimally invasive surgery among women with endometrial cancer","volume":"142","author":"Freeman","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109649_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2021.12.011","article-title":"Low incidence of venous thromboembolism after gynecologic oncology surgery: who is at greatest risk?","volume":"164","author":"Swift","year":"2022","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:46:33Z","timestamp":1753973193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0748798325000770"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109649","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after gynecological cancer surgery: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109649"}}